Metropolis Healthcare P/E Ratio
Metropolis Healthcare P/E ratio. Metropolis Healthcare (METROPOLIS) P/E ratio is 52.9 (High), EPS (TTM) ₹9.19, current price ₹558.70 on NSE vs historical average P/E of 60.25 (28.6th percentile) — Very High - High growth expectations or significantly overvalued. Also explore METROPOLIS share price data to track price trends across different timeframes.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
METROPOLIS P/E Ratio — Valuation Signal & Historical Context
Metropolis Healthcare P/E 52.9 vs historical average 60.25, range 32.92–118.44 — signal: Overvalued. Check Metropolis Healthcare networth to track the company's total market size over time.
- Stock appears overvalued with PE of 52.9, suggesting caution for new investments
Metropolis Healthcare P/E Ratio Historical Trend
METROPOLIS annual price-to-earnings ratio — 7 years, EPS and year-end price. Current P/E 52.9 vs historical average 60.25. For live price, revenue and the complete fundamental profile, see METROPOLIS screener.
METROPOLIS Historical P/E Ratio — EPS, Year-End Price & Valuation
Metropolis Healthcare annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 63.18 | 32.55 | ₹2056.50 | NSE | High |
| 2024 | 56.34 | 29.72 | ₹1674.55 | NSE | High |
| 2023 | 54.11 | 24.35 | ₹1317.65 | NSE | High |
| 2022 | 118.44 | 29.21 | ₹3459.65 | NSE | High |
| 2021 | 43.7 | 46.11 | ₹2015.00 | NSE | High |
| 2020 | 53.06 | 27.04 | ₹1434.65 | NSE | High |
| 2019 | 32.92 | 29.16 | ₹959.85 | NSE | High |
METROPOLIS vs Healthcare Peers — P/E Ratio Comparison
Metropolis Healthcare P/E 52.9 vs Healthcare average 52.19, median 29.4 — range 2.0–733.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |